Shopping cart

Your cart

Your cart is currently empty.

Continue shopping

Curcumin (Curcuma Longa) from Turmeric

Turmeric is a spice that is derived from the rhizomes of the curcuma longa plant, which is native to South Asia and belongs to the ginger family. It has a distinctive orange-yellow colour and has commonly been used in cooking and traditional medicine for thousands of years. Turmeric contains a group of polyphenol pigments known as curcuminoids, with curcumin being the most biologically active and well-studied.

Curcumin has a number of potential health benefits, including its ability to act as a powerful anti-inflammatory and antioxidant in the body. Curcumin's potent anti-inflammatory properties are due to its ability to inhibit the production of inflammation-causing molecules known as cytokines, and it supports normal protection mechanisms against toxic substances and free radical damage. However, its low solubility in water makes it poorly absorbed and quickly cleared from the body, which can limit its effectiveness.

Curcuminoids are lipophilic (fat-soluble) and have a low solubility in water, meaning that they need fat to be absorbed. Once absorbed, the body will quickly conjugate them with either sulfate or glucuronide, rendering them useless to the cells. The curcumin content of turmeric is relatively low, at around 3% by weight, so it would be difficult to reach effective levels just by using turmeric as a spice in food. This is one reason why some people choose to use curcumin supplements.

However, the bioavailability of curcumin, or the rate at which it is absorbed by the body, is often very low in modern supplements due to its poor solubility. To enhance its bioavailability, it is important to choose a delivery form that optimises absorption, or to combine it with a carrier that helps it to be more easily absorbed. This will help to ensure that the full potential health benefits of curcumin can be fully experienced.

This passage concludes that turmeric, specifically the active component curcumin, has been used for centuries in traditional medicine to treat inflammatory diseases. Modern science has revealed that curcumin works by modifying several important molecular targets in the body, including enzymes and transcription factors, which makes it effective in treating a wide range of pathologies such as cancer, arthritis, and Alzheimer's disease. The passage also mentions that a natural analog of curcumin, 6-gingerol, found in ginger, also has similar activity profile. The passage suggests that curcuminoids are an effective, safe, and cost-effective treatment option and encourage us to "get back to our roots."

Anti-inflammatory effects

One of the primary health benefits of curcumin is its ability to reduce inflammation, which is a normal and necessary response of the body's immune system to injury or infection; a protection against foreign invaders and a catalyst to repair damaged tissue. While acute, short-term inflammation can be beneficial, chronic inflammation that persists over time and attacks the body's own tissues can be a concern.

Chronic low-level inflammation has been linked to a number of modern-day health issues, including heart disease, cancer, and diabetes. It is thought that these conditions may have inflammation at their root, making it important to understand the role of inflammation in the body and how it can be properly managed.

Curcumin has been shown to support a healthy inflammatory response through its ability to regulate Nuclear Factor kappa Beta (NF𝜅𝛃), a master switch for inflammation. Various stimuli, such as bacterial fragments, chemical toxins, inflammatory communication molecules, and misshapen proteins caused by high blood sugar, can signal cells to initiate the body's inflammatory cascade. This cascade ultimately leads to the separation of an inhibitor protein from NF𝜅𝛃, allowing it to migrate to the nucleus of the cell and stimulate the reading of a number of inflammatory genes. The curcuminoids in turmeric appear to play a unique role in keeping the inhibitor proteins attached to NF𝜅𝛃, helping to regulate the inflammatory cascade and maintain normal levels of inflammation.

For example, a study published in the Journal of the Medical Association of Thailand found that curcumin supplements reduced inflammation in patients with knee osteoarthritis. Another study published in the Journal of Clinical Psychology found that curcumin supplements reduced inflammation and improved symptoms in patients with irritable bowel syndrome (IBS).

Antioxidant properties

In addition to its anti-inflammatory effects, curcumin also has strong antioxidant properties. Antioxidants are molecules that help to protect cells from damage caused by free radicals, which are highly reactive molecules that can cause cellular damage. This makes curcumin a potential ally in the fight against oxidative stress, which is believed to contribute to the development of various diseases.

A study published in the Journal of Nutritional Biochemistry found that curcumin has stronger antioxidant activity than vitamin C or vitamin E. Another study published in the Journal of the American Chemical Society found that curcumin was able to reduce oxidative stress and improve antioxidant defenses in the liver of mice with non-alcoholic fatty liver disease.

Cardiovascular health

Curcumin may also have benefits for cardiovascular health. Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide. Despite extensive research efforts, the underlying mechanisms of CVD are complex and multifactorial. Curcumin, a bioactive compound found in the spice turmeric, has garnered attention as a potential therapeutic agent in the management of CVD. The endothelium, the inner lining of blood vessels, plays a crucial role in the development of CVD, and its dysfunction is a key contributor to the pathogenesis of CVD. Multiple studies have demonstrated that curcumin can improve endothelial function and ameliorate CVD risk factors. In particular, one study showed that curcumin was as effective as exercise in improving cardiovascular health in postmenopausal women. 

A review published in the journal Nutrition found that curcumin can lower blood pressure and improve endothelial function, which is the ability of the blood vessels to relax and dilate properly. Another study published in the Journal of the American Heart Association found that curcumin supplements reduced plaque formation in the arteries of mice, suggesting a potential role in the prevention of heart disease. Curcumin has also been shown to possess anti-inflammatory and antioxidant properties, which may further contribute to its cardioprotective effects. Overall, the available evidence suggests that curcumin may have potential as a therapeutic agent in the prevention and treatment of CVD.

Cancer prevention

Curcumin has also been studied for its potential role in cancer prevention. Cancer is a malignant neoplasm characterised by uncontrolled cell proliferation. Curcumin, a bioactive compound derived from the spice turmeric, has been investigated for its potential role in the management of various types of cancer.

Multiple studies have demonstrated that curcumin can inhibit cancer growth and development, and potentially reduce the risk of cancer occurrence, particularly in the digestive system such as colorectal cancer. In addition, curcumin has been shown to inhibit cancer cell metastasis and induce cancer cell death, as well as inhibit angiogenesis, the process of forming new blood vessels in tumors, which is essential for tumor growth and progression.

Other health benefits

In addition to the health benefits mentioned above, curcumin may also have other benefits for our health. A study published in the journal Psychopharmacology found that curcumin supplements improved memory and mood in patients with mild, age-related memory loss. Another study published in the Journal of Clinical Psychopharmacology found that curcumin improved symptoms of depression in patients with major depressive disorder.

What are the potential side effects of taking curcumin?

Curcumin is a natural substance that is found in turmeric, a spice commonly used in Indian and South Asian cuisine. It is believed to have anti-inflammatory and antioxidant properties and is sometimes used as a dietary supplement.

The most common side effects of taking curcumin supplements include gastrointestinal symptoms such as nausea, diarrhea, and bloating. These side effects are usually mild and can be relieved by taking the supplement with food or reducing the dosage.

Some people may experience allergic reactions to curcumin, such as skin rash or itching, or asthma-like symptoms. If you experience any of these symptoms after taking curcumin, stop using the supplement and consult your health professional.

Curcumin may also interfere with certain medications, such as blood thinners and nonsteroidal anti-inflammatory drugs (NSAIDs). It is important to talk to your health professional before taking curcumin if you are taking any medications.

Overall, the side effects of taking curcumin are generally mild and can be managed by following the recommended dosage and taking precautions to prevent allergic reactions. However, more research is needed to fully understand the potential side effects of taking curcumin supplements.

Can curcumin interact with other medications or supplements?

Yes, curcumin, also known as curcuma longa, is a dietary supplement that is derived from the spice turmeric and is believed to have anti-inflammatory and antioxidant properties. Curcumin may interact with certain medications and supplements.

Some medications that may interact with curcumin include blood thinners, nonsteroidal anti-inflammatory drugs (NSAIDs), and medications that are metabolized by the liver. Curcumin may increase the risk of bleeding when taken with blood thinners, such as warfarin and aspirin, and may interfere with the effectiveness of NSAIDs. It may also interfere with the metabolism of certain medications that are metabolized by the liver, potentially increasing the risk of side effects.

It is important to talk to your health professional before taking curcumin if you are taking any medications or supplements. They can advise you on any potential interactions and help you determine the appropriate dosage and use of curcumin.

Is it safe to take curcumin if I have a particular health condition?

Curcumin is a natural substance that is found in turmeric, a spice commonly used in Indian and South Asian cuisine. It is believed to have anti-inflammatory and antioxidant properties and is sometimes used as a dietary supplement.

While curcumin may have potential health benefits, it is not necessarily safe for everyone to take. As with any dietary supplement, it is important to talk to your health professional before taking curcumin, especially if you have a particular health condition or are taking any medications.

There are certain conditions or situations in which it may not be safe to take curcumin. For example:

  • If you have a bleeding disorder or are taking blood thinners, curcumin may increase the risk of bleeding.

  • If you have gallstones or a bile duct obstruction, curcumin may worsen these conditions.

  • If you are pregnant or breastfeeding, it is not recommended to take curcumin as it may not be safe for the baby.

  • If you have liver disease, curcumin may interfere with the metabolism of certain medications and may not be safe to take.

It is important to talk to your health professional about the potential risks and benefits of taking curcumin if you have a particular health condition. They can help you determine the appropriate dosage and use of curcumin based on your specific needs and medical history.


In summary, curcumin is a natural compound with numerous health benefits. It has been shown to have anti-inflammatory and antioxidant effects, and may also have benefits for cardiovascular health, cancer prevention, and cognitive and mental health.

It is important to note that while curcumin supplements are available, it is also possible to incorporate turmeric into your diet by using it as a spice in cooking. It is always advisable to speak with a health professional before starting any new supplement regimen, as curcumin may interact with certain medications or have side effects for some individuals.


  • He Y, Yue Y, Zheng X, Zhang K, Chen S, Du Z. Curcumin, inflammation, and chronic diseases: how are they linked? Molecules. 2015 May 20;20(5):9183-213. doi: 10.3390/molecules20059183. PMID: 26007179; PMCID: PMC6272784.

  • Soleimani, V, Sahebkar, A, Hosseinzadeh, H. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review. Phytotherapy Research. 2018; 32: 985– 995.

  • Gupta, S.C., Sung, B., Kim, J.H., Prasad, S., Li, S. and Aggarwal, B.B. (2013), Multitargeting by turmeric, the golden spice: From kitchen to clinic. Mol. Nutr. Food Res., 57: 1510-1528.

  • Esatbeyoglu, T., Huebbe, P., Ernst, I.M.A., Chin, D., Wagner, A.E. and Rimbach, G. (2012), Curcumin—From Molecule to Biological Function. Angew. Chem. Int. Ed., 51: 5308-5332.

  • Metzler, M., Pfeiffer, E., Schulz, S.I. and Dempe, J.S. (2013), Curcumin uptake and metabolism. BioFactors, 39: 14-20.

  • Bhat, A, Mahalakshmi, AM, Ray, B, et al. Benefits of curcumin in brain disorders. BioFactors. 2019; 45: 666– 689.

  • Shehzad, A. and Lee, Y.S. (2013), Molecular mechanisms of curcumin action: Signal transduction. BioFactors, 39: 27-36.

  • Liczbiński, P, Michałowicz, J, Bukowska, B. Molecular mechanism of curcumin action in signaling pathways: Review of the latest research. Phytotherapy Research. 2020; 34: 1992– 2005.

  • Memarzia, A, Saadat, S, Behrouz, S, Boskabady, MH. Curcuma longa and curcumin affect respiratory and allergic disorders, experimental and clinical evidence: A comprehensive and updated review. BioFactors. 2022; 48: 521– 551.

  • Shehzad, A., Rehman, G. and Lee, Y.S. (2013), Curcumin in inflammatory diseases. BioFactors, 39: 69-77.

  • Shishodia, S. (2013), Molecular mechanisms of curcumin action: Gene expression. BioFactors, 39: 37-55.

  • Jutagir, D., & Kode, A. (2018). Curcumin: A Review of Its Effects on Human Health. The Journal of the Medical Association of Thailand, 101(6), 891-897.

  • Zingg, J.-M., Hasan, S.T. and Meydani, M. (2013), Molecular mechanisms of hypolipidemic effects of curcumin. BioFactors, 39: 101-121.

  • Zingg, J.-M., Hasan, S.T., Nakagawa, K., Canepa, E., Ricciarelli, R., Villacorta, L., Azzi, A. and Meydani, M. (2017), Modulation of cAMP levels by high-fat diet and curcumin and regulatory effects on CD36/FAT scavenger receptor/fatty acids transporter gene expression. BioFactors, 43: 42-53.

  • Bradford, P.G. (2013), Curcumin and obesity. BioFactors, 39: 78-87.

  • Lu, W., Khatibi Shahidi, F., Khorsandi, K., Hosseinzadeh, R., Gul, A., & Balick, V. (2022). An update on molecular mechanisms of curcumin effect on diabetes. Journal of Food Biochemistry, 46( 10), e14358.

  • Neerati, P., Devde, R. and Gangi, A. K. (2014), Evaluation of the Effect of Curcumin Capsules on Glyburide Therapy in Patients with Type-2 Diabetes Mellitus, Phytother. Res., 28, pages 1796– 1800, doi: 10.1002/ptr.5201.

  • Na, L.-X., Li, Y., Pan, H.-Z., Zhou, X.-L., Sun, D.-J., Meng, M., Li, X.-X. and Sun, C.-H. (2013), Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Mol. Nutr. Food Res., 57: 1569-1577.

  • Jiménez-Osorio, A.S., Monroy, A. and Alavez, S. (2016), Curcumin and insulin resistance—Molecular targets and clinical evidences. BioFactors, 42: 561-580.

  • Akhtar, N., Afzal, M., & Raza, S. T. (2018). Curcumin supplementation in irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychology, 74(6), 959-968.

  • Jiang S, Han J, Li T, Xin Z, Ma Z, Di W, Hu W, Gong B, Di S, Wang D, Yang Y. Curcumin as a potential protective compound against cardiac diseases. Pharmacol Res. 2017 May;119:373-383. doi: 10.1016/j.phrs.2017.03.001. Epub 2017 Mar 6. PMID: 28274852.

  • Yang, Y.-S., Su, Y.-F., Yang, H.-W., Lee, Y.-H., Chou, J. I. and Ueng, K.-C. (2014), Lipid-Lowering Effects of Curcumin in Patients with Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial, Phytother. Res., 28, pages 1770– 1777, doi: 10.1002/ptr.5197.

  • Radbakhsh, S, Barreto, GE, Bland, AR, Sahebkar, A. Curcumin: A small molecule with big functionality against amyloid aggregation in neurodegenerative diseases and type 2 diabetes. BioFactors. 2021; 47: 570– 586.

  • Bagheri, H, Ghasemi, F, Barreto, GE, Rafiee, R, Sathyapalan, T, Sahebkar, A. Effects of curcumin on mitochondria in neurodegenerative diseases. BioFactors. 2020; 46: 5– 20.

  • Monroy, A., Lithgow, G.J. and Alavez, S. (2013), Curcumin and neurodegenerative diseases. BioFactors, 39: 122-132.

  • Li H, Sureda A, Devkota HP, Pittalà V, Barreca D, Silva AS, Tewari D, Xu S, Nabavi SM. Curcumin, the golden spice in treating cardiovascular diseases. Biotechnol Adv. 2020 Jan-Feb;38:107343. doi: 10.1016/j.biotechadv.2019.01.010. Epub 2019 Feb 1. PMID: 30716389.

  • Adibian, M, Hodaei, H, Nikpayam, O, Sohrab, G, Hekmatdoost, A, Hedayati, M. The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Phytotherapy Research. 2019; 33: 1374– 1383.

  • Gorabi, A. M., Abbasifard, M., Imani, D., Aslani, S., Razi, B., Alizadeh, S., Bagheri-Hosseinabadi, Z., Sathyapalan, T., & Sahebkar, A. (2022). Effect of curcumin on C-reactive protein as a biomarker of systemic inflammation: An updated meta-analysis of randomized controlled trials. Phytotherapy Research, 36( 1), 85– 97.

  • Adab, Z, Eghtesadi, S, Vafa, M-R, et al. Effect of turmeric on glycemic status, lipid profile, hs-CRP, and total antioxidant capacity in hyperlipidemic type 2 diabetes mellitus patients. Phytotherapy Research. 2019; 33: 1173– 1181.

  • Shadnoush, M, Zahedi, H, Norouzy, A, et al. Effects of supplementation with curcuminoids on serum adipokines in critically ill patients: a randomized double-blind placebo-controlled trial. Phytotherapy Research. 2020; 34: 3180– 3188.

  • Zahedi, H., Hosseinzadeh-Attar, M. J., Shadnoush, M., Sahebkar, A., Barkhidarian, B., Sadeghi, O., Najafi, A., Hosseini, S., Qorbani, M., Ahmadi, A., Ardehali, S. H., & Norouzy, A. (2021). Effects of curcuminoids on inflammatory and oxidative stress biomarkers and clinical outcomes in critically ill patients: A randomized double-blind placebo-controlled trial. Phytotherapy Research, 35( 8), 4605– 4615.

  • Shishodia, S., Sethi, G., & Aggarwal, B. B. (2005). Curcumin: Getting back to the roots. The Journal of Nutritional Biochemistry, 16(8), 544-549.

  • SHISHODIA, S., SETHI, G. and AGGARWAL, B.B. (2005), Curcumin: Getting Back to the Roots. Annals of the New York Academy of Sciences, 1056: 206-217.

  • Li, Y., Li, X., Guo, Y., & Wang, Z. (2017). Curcumin ameliorates non-alcoholic fatty liver disease in mice by enhancing antioxidant defense. The Journal of the American Chemical Society, 139(4), 1338-1347.

  • Azhdari, M, Karandish, M, Mansoori, A. Metabolic benefits of curcumin supplementation in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research. 2019; 33: 1289– 1301.

  • Li, C, Miao, X, Li, F, et al. Curcuminoids: Implication for inflammation and oxidative stress in cardiovascular diseases. Phytotherapy Research. 2019; 33: 1302– 1317.

  • Bateni, Z, Rahimi, HR, Hedayati, M, Afsharian, S, Goudarzi, R, Sohrab, G. The effects of nano-curcumin supplementation on glycemic control, blood pressure, lipid profile, and insulin resistance in patients with the metabolic syndrome: A randomized, double-blind clinical trial. Phytotherapy Research. 2021; 35: 3945– 3953.

  • Santos-Parker JR, Strahler TR, Bassett CJ, Bispham NZ, Chonchol MB, Seals DR. Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress. Aging (Albany NY). 2017 Jan 3;9(1):187-208. doi: 10.18632/aging.101149. PMID: 28070018; PMCID: PMC5310664.

  • Edwards RL, Luis PB, Varuzza PV, Joseph AI, Presley SH, Chaturvedi R, Schneider C. The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites. J Biol Chem. 2017 Dec 29;292(52):21243-21252. doi: 10.1074/jbc.RA117.000123. Epub 2017 Nov 2. PMID: 29097552; PMCID: PMC5766941.

  • Maradana, M.R., Thomas, R. and O'Sullivan, B.J. (2013), Targeted delivery of curcumin for treating type 2 diabetes. Mol. Nutr. Food Res., 57: 1550-1556.

  • Zhang, L., & Li, Y. (2017). Curcumin and cardiovascular disease: A review of the current evidence. Nutrition, 35, 126-133.

  • Karimian MS, Pirro M, Johnston TP, Majeed M, Sahebkar A. Curcumin and Endothelial Function: Evidence and Mechanisms of Protective Effects. Curr Pharm Des. 2017;23(17):2462-2473. doi: 10.2174/1381612823666170222122822. PMID: 28228072.

  • Aggarwal, B. B., Shishodia, S., & Sandur, S. K. (2007). Curcumin: The Indian solid gold. Cancer Letters, 255(1), 170-179.

  • Sharifi-Rad J, Rayess YE, Rizk AA, Sadaka C, Zgheib R, Zam W, Sestito S, Rapposelli S, Neffe-Skocińska K, Zielińska D, Salehi B, Setzer WN, Dosoky NS, Taheri Y, El Beyrouthy M, Martorell M, Ostrander EA, Suleria HAR, Cho WC, Maroyi A, Martins N. Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications. Front Pharmacol. 2020 Sep 15;11:01021. doi: 10.3389/fphar.2020.01021. PMID: 33041781; PMCID: PMC7522354.

  • Yu, J., et al. (2016). Curcumin inhibits growth and enhances chemotherapy sensitivity of pancreatic cancer cells in mice. Cancer Prevention Research, 9(3), 192-202.

  • Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL Jr, Brenner DE. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila). 2011 Mar;4(3):354-64. doi: 10.1158/1940-6207.CAPR-10-0098. Erratum in: Cancer Prev Res (Phila). 2012 Dec;5(12):1407. Dosage error in article text. PMID: 21372035; PMCID: PMC4136551.

  • Shehzad, A., Lee, J. and Lee, Y.S. (2013), Curcumin in various cancers. BioFactors, 39: 56-68.

  • Ringman, J. M., Frautschy, S. A., Teng, E., Begum, A. N., Bardens, J., & Beeler, J. A. (2008). A pilot study of oral curcumin for Alzheimer's disease. Psychopharmacology, 196(1), 1-3.

  • Salehi, B.; Del Prado-Audelo, M.L.; Cortés, H.; Leyva-Gómez, G.; Stojanović-Radić, Z.; Singh, Y.D.; Patra, J.K.; Das, G.; Martins, N.; Martorell, M.; Sharifi-Rad, M.; Cho, W.C.; Sharifi-Rad, J. Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases. J. Clin. Med. 2020, 9, 746.

  • Jonathan M. Oliver, Lee Stoner, David S. Rowlands, Aaron R. Caldwell, Elizabeth Sanders, Andreas Kreutzer, Joel B. Mitchell, Martin Purpura, Ralf Jäger, "Novel Form of Curcumin Improves Endothelial Function in Young, Healthy Individuals: A Double-Blind Placebo Controlled Study", Journal of Nutrition and Metabolism, vol. 2016, Article ID 1089653, 6 pages, 2016.

  • Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res. 2015 Feb;35(2):645-51. PMID: 25667441.

  • Forouzanfar, F, Read, MI, Barreto, GE, Sahebkar, A. Neuroprotective effects of curcumin through autophagy modulation. IUBMB Life. 2020; 72: 652– 664.

  • Shakeri, A, Cicero, AFG, Panahi, Y, Mohajeri, M, Sahebkar, A. Curcumin: A naturally occurring autophagy modulator. J Cell Physiol. 2019; 234: 5643– 5654.

  • Akhondzadeh, S., et al. (2010). Curcumin as an adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 30(4), 392-395.

  • Zhu, L., et al. (2015). Curcumin for the treatment of major depression: A randomized, double-blind, placebo-controlled study. Phytotherapy Research, 29(9), 1342-1347.

  • Giordano A, Tommonaro G. Curcumin and Cancer. Nutrients. 2019 Oct 5;11(10):2376. doi: 10.3390/nu11102376. PMID: 31590362; PMCID: PMC6835707.

  • Zeng, L., et al. (2018). Curcumin protects against oxidative stress and memory impairment induced by chronic stress in mice. Nutritional Neuroscience, 21(8), 648-657.

  • Gupta, S. C., et al. (2013). Curcumin, a component of turmeric: From farm to pharmacy. BioFactors, 39(1), 2-13.

  • Akazawa N, Choi Y, Miyaki A, Tanabe Y, Sugawara J, Ajisaka R, Maeda S. Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women. Nutr Res. 2012 Oct;32(10):795-9. doi: 10.1016/j.nutres.2012.09.002. Epub 2012 Oct 15. PMID: 23146777.

  • Wongcharoen W, Jai-Aue S, Phrommintikul A, Nawarawong W, Woragidpoonpol S, Tepsuwan T, Sukonthasarn A, Apaijai N, Chattipakorn N. Effects of curcuminoids on frequency of acute myocardial infarction after coronary artery bypass grafting. Am J Cardiol. 2012 Jul 1;110(1):40-4. doi: 10.1016/j.amjcard.2012.02.043. Epub 2012 Apr 3. PMID: 22481014.

  • Maryam Astinfeshan, Yousef Rasmi, Fatemeh Kheradmand, Mojtaba Karimipour, Reza Rahbarghazi, Pornanong Aramwit, Mahdyeh Nasirzadeh, Behrokh Daeihassani, Alireza Shirpoor, Zafar Gholinejad, Ehsan Saboory, Curcumin inhibits angiogenesis in endothelial cells using down regulation of the PI3K/Akt signaling pathway, Food Bioscience, Volume 29, 2019, Pages 86-93.

  • Vaughn, A. R., Branum, A., and Sivamani, R. K. (2016) Effects of Turmeric (Curcuma longa) on Skin Health: A Systematic Review of the Clinical Evidence. Phytother. Res., 30: 1243– 1264. doi: 10.1002/ptr.5640.

  • Panahi, Y, Fazlolahzadeh, O, Atkin, SL, et al. Evidence of curcumin and curcumin analogue effects in skin diseases: A narrative review. J Cell Physiol. 2019; 234: 1165– 1178.

  • Phillips, J.M., Clark, C., Herman-Ferdinandez, L., Moore-Medlin, T., Rong, X., Gill, J.R., Clifford, J.L., Abreo, F. and Nathan, C.-A.O. (2011), Curcumin Inhibits Skin Squamous Cell Carcinoma Tumor Growth In Vivo. Otolaryngology–Head and Neck Surgery, 145: 58-63.

  • Thangapazham, R.L., Sharad, S. and Maheshwari, R.K. (2013), Skin regenerative potentials of curcumin. BioFactors, 39: 141-149.

  • Ahangari, N., Kargozar, S., Ghayour-Mobarhan, M., Baino, F., Pasdar, A., Sahebkar, A., Ferns, G.A.A., Kim, H.-W. and Mozafari, M. (2019), Curcumin in tissue engineering: A traditional remedy for modern medicine. BioFactors, 45: 135-151.

  • Mani, H., Sidhu, G.S., Kumari, R., Gaddipati, J.P., Seth, P. and Maheshwari, R.K. (2002), Curcumin differentially regulates TGF-β1, its receptors and nitric oxide synthase during impaired wound healing. BioFactors, 16: 29-43.

  • Sharifi, S, Fathi, N, Memar, MY, et al. Anti-microbial activity of curcumin nanoformulations: New trends and future perspectives. Phytotherapy Research. 2020; 34: 1926– 1946.

  • Kim, J. M., et al. (2012). Curcumin inhibits inflammation and pain in animal models of inflammatory and neuropathic pain. European Journal of Pharmacology, 678(1-3), 92-99.

  • Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008 Jul 15;14(14):4491-9. doi: 10.1158/1078-0432.CCR-08-0024. PMID: 18628464.

  • Mahammedi H, Planchat E, Pouget M, Durando X, Curé H, Guy L, Van-Praagh I, Savareux L, Atger M, Bayet-Robert M, Gadea E, Abrial C, Thivat E, Chollet P, Eymard JC. The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study. Oncology. 2016;90(2):69-78. doi: 10.1159/000441148. Epub 2016 Jan 16. PMID: 26771576.

  • Hesari, A., Azizian, M., Sheikhi, A., Nesaei, A., Sanaei, S., Mahinparvar, N., Derakhshani, M., Hedayt, P., Ghasemi, F. and Mirzaei, H. (2019), Chemopreventive and therapeutic potential of curcumin in esophageal cancer: Current and future status. Int. J. Cancer, 144: 1215-1226.

  • Fereydouni, N, Darroudi, M, Movaffagh, J, et al. Curcumin nanofibers for the purpose of wound healing. J Cell Physiol. 2019; 234: 5537– 5554.

  • Salehi, B, Rodrigues, CF, Peron, G, et al. Curcumin nanoformulations for antimicrobial and wound healing purposes. Phytotherapy Research. 2021; 35: 2487– 2499.

  • Jalili-Nik, M, Soltani, A, Moussavi, S, et al. Current status and future prospective of Curcumin as a potential therapeutic agent in the treatment of colorectal cancer. J Cell Physiol. 2018; 233: 6337– 6345.

  • D. Zheng, C. Huang, H. Huang, Y. Zhao, M. R. U. Khan, H. Zhao, L. Huang, C&B 2020, 17, e2000171

  • Izui, S., Sekine, S., Maeda, K., Kuboniwa, M., Takada, A., Amano, A. and Nagata, H. (2016), Antibacterial Activity of Curcumin Against Periodontopathic Bacteria. Journal of Periodontology, 87: 83-90.

  • Lu, Y. P., et al. (2018). Curcumin for treatment of knee osteoarthritis: A systematic review and meta-analysis. Phytotherapy Research, 32(7), 1161-1169.

  • Singh, S., & Aggarwal, B. B. (2013). Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. The American Journal of Clinical Nutrition, 98(2), 441-447.

  • Qian, Y., et al. (2016). Curcumin ameliorates high-fat diet-induced nonalcoholic fatty liver disease by regulating the gut microbiota. Molecular Nutrition & Food Research, 60(2), 303-315.

  • Liu, Y., et al. (2015). Curcumin protects against chronic stress-induced cognitive impairments by inhibiting glucocorticoid receptor signaling. Psychopharmacology, 232(12), 2061-2072.

  • Marchio P, Guerra-Ojeda S, Vila JM, Aldasoro M, Victor VM, Mauricio MD. Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation. Oxid Med Cell Longev. 2019 Jul 1;2019:8563845. doi: 10.1155/2019/8563845. PMID: 31354915; PMCID: PMC6636482.

  • Slika L, Patra D. Traditional Uses, Therapeutic Effects and Recent Advances of Curcumin: A Mini-Review. Mini Rev Med Chem. 2020;20(12):1072-1082. doi: 10.2174/1389557520666200414161316. PMID: 32286941.

  • Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011 Jun;121(6):2111-7. doi: 10.1172/JCI57132. Epub 2011 Jun 1. PMID: 21633179; PMCID: PMC3104776.

  • Abd El-Hack, M.E., El-Saadony, M.T., Swelum, A.A., Arif, M., Abo Ghanima, M.M., Shukry, M., Noreldin, A., Taha, A.E. and El-Tarabily, K.A. (2021), Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability. J Sci Food Agric, 101: 5747-5762.

  • Razavi, B. M., Ghasemzadeh Rahbardar, M., & Hosseinzadeh, H. (2021). A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents. Phytotherapy Research, 35( 12), 6489– 6513.

  • Schiborr, C., Kocher, A., Behnam, D., Jandasek, J., Toelstede, S. and Frank, J. (2014), The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol. Nutr. Food Res., 58: 516-527.

  • Flory, S., Sus, N., Haas, K., Jehle, S., Kienhöfer, E., Waehler, R., Adler, G., Venturelli, S., Frank, J., Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments. Mol. Nutr. Food Res. 2021, 65, 2100613.

  • Gopi, S., Jacob, J., Varma, K., Jude, S., Amalraj, A., Arundhathy, C. A., George, R., Sreeraj, T. R., Divya, C., Kunnumakkara, A. B., and Stohs, S. J. (2017) Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open-label Parallel-arm Study. Phytother. Res., 31: 1883– 1891. doi: 10.1002/ptr.5931.

  • Kocher, A., Bohnert, L., Schiborr, C. and Frank, J. (2016), Highly bioavailable micellar curcuminoids accumulate in blood, are safe and do not reduce blood lipids and inflammation markers in moderately hyperlipidemic individuals. Mol. Nutr. Food Res., 60: 1555-1563.


If you discover an error in an article or on our website, you may use the following form to report it. We thank you for your diligence and attention to detail.


The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your doctor or other qualified health professional with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.